Investor Relations

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

Stock Quote

Price / Change

42.74

0.82

Ticker:
HPTX
Exchange:
NASDAQ
Day High:
45.40
Day Low:
40.69
Volume:
638,500

4:00 PM ET on March 27, 2015
Delayed at least 20 minutes.
Provided by eSignal.